Showing 1421-1430 of 4065 results for "".
Targeting Epicardial Adipose Tissue in Patients With HFpEF Without Diabetes: Sotagliflozin Effect From SOTA-P-CARDIA Trial Sub-Analysis
https://reachmd.com/clinical-practice/cardiology/targeting-epicardial-adipose-tissue-in-patients-with-hfpef-without-diabetes-sotagliflozin-effect-from-sota-p-cardia-trial-sub-analysis/49274/Review SOTA-P-CARDIA sub-analysis findings on the effects of sotagliflozin on epicardial adipose tissue in patients with HFpEF without diabetes.Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
https://reachmd.com/clinical-practice/cardiology/sotagliflozin-in-hfpef-without-diabetes-inside-the-sota-p-cardia-trial-from-aha-2025/39898/SOTA-P-CARDIA shows sotagliflozin improves LV mass, exercise capacity, and quality of life in non-diabetic HFpEF, supporting dual SGLT1/2 inhibition.Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/sustained-antidepressant-and-sleep-benefits-with-adjunctive-seltorexant-in-mdd-double-blind-and-long-term-extension-data-from-the-md3001-trial/36555/Review Phase 3 MD3001 trial data on adjunctive seltorexant in MDD with insomnia, including double-blind efficacy and 1-year extension safety outcomes.Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/valbenazine-and-patient-centered-outcomes-in-td-insights-from-the-kinect-pro-study/36175/Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO StudyValbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/valbenazine-for-td-consistent-long-term-efficacy-across-racial-and-ethnic-subgroups-in-kinect-4/37642/Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4The Role of HCC Coding in Dermatology
https://reachmd.com/topics/practice-management/the-role-of-hcc-coding-in-dermatology/56303/Hierarchical Condition Category (HCC) coding has become a cornerstone for risk adjustment in modern healthcare systems, serving to ensure appropriate reimbursement for providers managing patients with complex medical needs.Precision Medicine for AD
https://reachmd.com/columns/atopic-dermatitis-essentials/precision-medicine-for-ad/54826/A Q & A with Derek MaetzoldFatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Return of Auras Following Treatment of Focal-Onset Seizures with Responsive Neurostimulation
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/return-of-auras-following-treatment-of-focal-onset-seizures-with-responsive-neurostimulation/32017/Ethics of Paired Exchanges and Donor Websites
https://reachmd.com/programs/clinicians-roundtable/ethics-of-paired-exchanges-and-donor-websites/790/In this segment, Dr. Millis examines the ethical issues of several modern organ donation methods, including paired exchange. Referenced and discussed in this discussion is the Norwood Living Organ Donation Act passed recently, and the challenges and controversies this development has brought. The in